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Background. We documented bacterial meningitis trends among adults and children presenting to a large teach-
ing hospital in Malawi during introduction of Haemophilus inﬂuenzae type b (Hib) vaccination and the rollout of
antiretroviral therapy (ART).
Methods. We analyzed data from 51 000 consecutive cerebrospinal ﬂuid (CSF) samples obtained from adults,
adolescents, and children with suspected meningitis admitted to the Queen Elizabeth Central Hospital, Blantyre,
Malawi, between 2000 and 2012.
Results. There was a signiﬁcant decline in the total number of CSF isolates over 12 years (incident rate ratio
[IRR], 0.93; 95% CI, .92–.94; P < .001). This decline was entirely in children aged <5 years (IRR, 0.87; 95% CI,
.85–.88; P < .001) and coincided with the introduction of Hib vaccination. The number of adult isolates has remained
unchanged (IRR, 0.99; 95% CI, .97–1.0; P = .135) despite rapid scale-up of ART provision. In children aged <5 years,
Streptococcus pneumoniae, nontyphoidal salmonellae (NTS), and Hib were the most frequently isolated pathogens,
and have declined over this time period. Streptococcus pneumoniae was the most frequently isolated pathogen in
older children and adults. Estimated incidence of bacterial meningitis in 2012 was 20 per 100 000 cases in children
aged <14 years, 6 per 100 000 adolescents, and 10 per 100 000 adults.
Conclusions. Rates of bacterial meningitis have declined in children, but not adults, coinciding with the intro-
duction of Hib vaccination. The highly successful rollout of ART has not yet resulted in a reduction in the incidence
in adults where the burden remains high. Long-term surveillance of bacterial meningitis outside of the epidemic
“meningitis belt” in Africa is essential.
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The burden of acute bacterial meningitis (ABM) across
sub-Saharan Africa is disproportionally higher than in
countries in the developed world [1]. The associated
mortality is more than twice that of developed countries
for both children (25%–36% vs 5%–11%) and adults
(54%–70% vs 25%–30%) [2–5].Outside the “meningitis
belt” where large epidemics of meningococcal meningi-
tis occur every 5–10 years, bacterial meningitis inci-
dence in children in Africa is estimated to be as high
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as 25 cases per 100 000 children [6], compared with 0.56 per
100 000 in children aged 2–10 years in the United States or
1–3 per 100 000 in the United Kingdom [7–9]. The incidence
in well-resourced countries continues to decline with the intro-
duction of meningococcal and pneumococcal vaccines [10]. Es-
timates of meningitis incidence in African adults are lacking,
but a higher burden of disease is likely, compared with re-
source-rich countries, particularly where human immunodeﬁ-
ciency virus (HIV) is highly prevalent [5]. In Malawi, where
the population prevalence of HIV is estimated to be 11.9%
[11], inpatient HIV prevalence is 70% in adults, and 85% in adults
with bacterial meningitis [12]. Of children with ABM in Malawi,
36% are HIV infected [13].
In the last 10 years, numerous public health interventions have
been introduced into Malawi, including Haemophilus inﬂuenzae
type b (Hib) vaccination in 2002 [14], intensiﬁcation of malaria
control in 2005 [15], rapid scale-up of antiretroviral therapy
(ART) in 2004, and co-trimoxazole preventive therapy in 2005
[16]. These measures have been associated with considerable im-
provements in under-5 childhood mortality and decreases in the
mortality rate of HIV-infected adults from 42% to 17% [17, 18].
However, it is less certain how these interventions have affected
the burden of ABM. We have been conducting surveillance for
invasive bacterial infections for almost 15 years at the largest dis-
trict and referral hospital in Malawi. We have taken advantage of
these consistently collected data to analyze trends in etiology and
disease incidence for ABM over a 12-year period.
METHODS
Setting
The Queen Elizabeth Central Hospital (QECH) in Blantyre,
Malawi, is a 1250-bed government-funded teaching hospital
providing free healthcare that serves approximately 1 million
people. The annual admission rate to QECH is 50 000 per year.
The diagnostic laboratory at the Malawi-Liverpool-Wellcome
Trust (MLW) Clinical Research Programme has provided a rou-
tine cerebrospinal ﬂuid (CSF) culture for clinically suspected
meningitis at QECH for >10 years.
Patients
Since 2000, all adults (aged ≥20 years) and children and adoles-
cents presenting with a clinical suspicion of meningitis routine-
ly underwent lumbar puncture (LP): 5–10 mL of CSF from
adults and adolescents, and 1–2 mL from children. LP was with-
held in patients with clear contraindications to the procedure
[19], but this was rare. Indications for LP did not change during
the study period. Culture-positive isolates were divided into
clinically relevant age groups: neonates (0 to <3 months of
age), Expanded Program on Immunization (EPI)–eligible chil-
dren (aged 3 months to <5 years), older children (aged 5–14
years), adolescents (aged 15–19 years), and adults (aged ≥20
years). Neonatal data were not analyzed as a separate group in
this study as neonatal meningitis is epidemiologically distinct
from community-acquired meningitis. However, these children
were included in the overall trend analysis due to a small num-
ber of isolates having no patient age assigned. This study con-
forms to institutional guidelines and practices. Data collection
was approved by the University of Malawi College of Medicine
Research Ethics Committee.
Pathogen Isolation and Identiﬁcation
Gram stain was performed if the CSF white cell count (WCC)
was >10 cells/µL. India ink stain was performed on adult CSF
samples. All samples were cultured on sheep blood and choco-
late agar for 48 hours under aerobic and microaerophilic con-
ditions. Bacteria and fungi were identiﬁed using standard
methods [20]. Antibiotic susceptibilities of all bacterial isolates
were determined by the disc diffusion method (Oxoid, United
Kingdom) using standard guidelines [21]. CSF biochemistry
was determined using a Beckman Coulter CX5 Synchron Pro
analyzer from 2009 onward.
Cryptococcal culture rates on blood agar were reported. My-
cobacterial CSF culture was not performed. All diagnostic test-
ing at the MLW Clinical Research Programme laboratory was
quality controlled as part of internationally recognized quality
control programs.
National HIV Intervention Strategies
In Blantyre, ART rollout began from QECH to health centers in
2004. ART Scale-up data were obtained from the Malawi Min-
istry of Health [22]. Data on co-trimoxazole preventive therapy
usage were not available.
Rainfall and Temperature
Rainfall and temperature data were obtained from the Depart-
ment of Climate Change and Meteorological Services, Malawi,
for 2 stations in Blantyre for 2000–2010. The cooler dry season
is between May and August, the hot dry season between Sep-
tember and November, and the rainy season between November
and April.
Incidence Rates
Midyear population estimates were based on projections from
the 1998 and 2008 Population and Housing Censuses [23]. In-
cidence was deﬁned as cases number in a deﬁned period divided
by population time observed. Changes in incidence over time
were plotted.
Time-Series Analysis
Time-series decomposition was used to separate long-term
trends from seasonal perturbations [24]. Symmetric locally
weighted moving averages were used, with less weight given
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to time points (in months) further from the present. A 5-month
window was used to detect seasonality:
Y^t ¼ 19 ðYt2 þ 2Yt1 þ 3Yt þ 2Ytþ1 þ Ytþ2Þ:
A 12-month window was used to construct a trend line that
would be sensitive to year-to-year changes but dampen noise
from seasonal perturbation:
bYt ¼ 124 ðYt6 þ Ytþ6Þ þ
1
12
ðYt þ Yt1 þ Ytþ1 þ Yt2 þ Ytþ2
þ Yt3 þ Ytþ3 þ Yt4 þ Ytþ4 þ Yt5 þ Ytþ5Þ:
To determine whether seasonal perturbation differed signiﬁcantly
from baseline, data were trend differenced. The distribution of re-
sidual ﬂuctuations for each month was compared to baseline with
2-tailed t test. To determine the impact of rainfall and tempera-
ture, an autoregressive integrated moving average model with
exogenous variables (ARMAX) model was used. Models using
speciﬁcations of the autoregressive and moving average parame-
ters were compared using the absolute percentage error.
Statistical Methods
The Kruskal-Wallis test was used to detect globally signiﬁcant
differences in the distribution of nonnormal variables among
groups of interest. Where results were signiﬁcant, pairwise com-
parisons were done using Mann-Whitney test. Poisson regres-
sion was used to derive incident rate ratios (IRRs) and 95%
conﬁdence intervals (CIs) over the 12-year period. Disease inci-
dence ratios pre- and postvaccination were derived using binary
(post–pre) rate ratios to estimate vaccine efﬁcacy. A P value <.05
denoted statistical signiﬁcance. Statistical and time series anal-
yses were done using Stata software, version 12.1 (StataCorp,
College Station, Texas).
RESULTS
Trends in Disease and Pathogen Incidence Over Time
The overall trends in all culture-positive cases of bacterial men-
ingitis in adults, adolescents, and children aged <20 years are
described in Figure 1A. There was a signiﬁcant annual decline
in the total number of CSF isolates between 2000 and 2012
(IRR, 0.93; 95% CI, .92–.94; P < .001). This decline was entirely
in children and adolescents (IRR, 0.87; 95% CI, .85–.88;
P < .001); the number of isolates from adults remained un-
changed (IRR, 0.99; 95% CI, .97–1.0; P = .135).The number of
CSF samples received by the laboratory each year remained
constant after 2002, and hospital admission rates did not chan-
ge during the study period, despite an increasing population.
Speciﬁc trends in the most commonly isolated pathogens in
children and adolescents are described in Figure 1B. These data
include all children from birth where the age is known, and a
small number of children (<5% total) where the age was not
documented but admission to a pediatric ward was recorded.
Cases of Hib meningitis declined 20-fold from 80 cases per
year in 2000 to <4 cases per year in 2012 in all children and ad-
olescents. Following Hib vaccination in 2002, cases declined
rapidly in the EPI-eligible, 3 months to <5 years age group
(Figure 1C). In the years immediately preceding and following
vaccine introduction, Hib incidence has dropped dramatically;
the binary IRR of the fall is 0.11 (95% CI, .08–.14; P < .001),
providing an estimated vaccine effectiveness of 89% (95% CI,
86%–92%). Childhood nontyphoidal salmonellae (NTS) and
pneumococcal meningitis cases have also signiﬁcantly declined
in children in this age group between 2002 and 2012; the IRR
over 12 years was 0.85 (95% CI, .81–.89; P < .001) for NTS, and
0.88 (95% CI, .85–.91; P < .001) for pneumococcus.
From these data, the overall incidence of culture-positive bac-
terial meningitis was estimated. Incidence declined from 49.6
per 100 000 in 2002 to 20 per 100 000 in 2012. This decline is
driven predominately by the 3 months to <5 years age group
(incidence 154.4 in 2002 to 20 in 2012), and the 5-15 years
group (incidence 15.7 in 2002 to 8 in 2012), with incidence in
adolescents and adults remaining unchanged (Figure 2).
Supplementary Figure 1A–D shows the proportions of all cul-
ture-positive isolates per age group. In the age group 3 months
to <5 years (Supplementary Figure 1A), there has been a decline
of 88% in the total number of microbiologically conﬁrmed
pathogens since 2000. Hib meningitis has dramatically declined
from >35% of all cases prior to 2002 to 3.5% in 2005, subse-
quently remaining between 10% and 15%. Streptococcus pneu-
moniae accounted for 30%–50% of cases in 2000–2003, but as
Hib cases declined, pneumococcus has consistently accounted
for >60% of cases since 2004. The number of pneumococcal iso-
lates in this age group has dropped from a peak of 115 out of
177 cases in 2007 to 16 per 25 cases in 2012. Nontyphoidal sal-
monellae meningitis caused approximately 23% of cases before
2004, dropping to <10% by 2012. Group B streptococcal men-
ingitis peaked in 2005 at almost 15%, but since 2009 has
dropped to <3%. Conﬁrmed meningococcal meningitis has re-
mained consistently at <5%. Pathogens listed as “other” have in-
creased in proportion as the other causes have decreased. This
group includes groups A and D streptococci, Klebsiella pneumo-
niae, Listeria monocytogenes, Salmonella enteritidis, Staphylococcus
aureus, and H. inﬂuenzae types a and c and nontypeables.
Streptococcus pneumoniae is the predominant bacterial path-
ogen causing 65% of infections in the 5- to 15-year age group;
Hib caused 8.6% and NTS <1% of infections (Supplementary
Figure 1B). Streptococcus pneumoniaewas also the predominant
pathogen in all older age groups >15 years; numbers ofNeisseria
meningitidis isolated from adults and adolescents were small
(Supplementary Figure 1C and 1D). Rapid up-scaling of ART
has led to >354 000 adults and >34 000 children starting ART
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Figure 1. Trends in culture positive isolates over time. A, Total numbers of culture-positive cases of bacterial meningitis, 2000–2012, by year. Isolates are
subdivided into adults aged >20 years and children and adolescents aged <20 years, compared with all cerebrospinal ﬂuid samples received by the lab-
oratory for analysis (right scale). B, Total numbers of culture-positive isolates by year and pathogen in all children and adolescents aged <20 years of
Streptococcus pneumoniae, nontyphoidal salmonellae (NTS), and Haemophillus inﬂuenzae (Hib) meningitis. C, Total numbers of culture-positive isolates
by year and pathogen in age-known Expanded Program on Immunization vaccine-eligible children aged ≥3 months to <5 years of S. pneumoniae, NTS, and
Hib meningitis. Abbreviations: CSF, cerebrospinal ﬂuid; Hib, Haemophilus inﬂuenzae; PCV13, 13-valent pneumococcal conjugate vaccine.
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by September 2012 in the Southern Region ofMalawi (Figure 3),
of which >215 000 adults and >21 000 children were reported to
be alive on ART at the end of 2012. However meningitis due to
Cryptococcus neoformans accounted for signiﬁcant and consis-
tent numbers of cases, particularly in adults in 2000–2012, with
the exception of the under-5 group, in whom cryptococcal men-
ingitis was detected only from 2009 onward (Supplementary
Figure 2).
Seasonality
We have previously described seasonal invasive pneumococcal
disease trends in Blantyre over the same time period [25] and
tested if bacterial meningitis is seasonal. Figure 4A and 4B de-
scribe the seasonality of meningitis due to S. pneumoniae and
Salmonella Typhimurium. Rainfall and temperature data were
available for the 2000–2010 period only.
The mean number of isolates per month of S. pneumoniae
were signiﬁcantly and consistently lower than the baseline
long-term trend during the wet season between December to
April over 10 years, despite the overall fall in isolate numbers
(P < .05). Using the ARMAX model, rainfall was associated
with 28% (95% CI, 13.7%–41.4%; P < .001) fewer cases of pneu-
mococcal meningitis. Hot weather was associated with 42.8%
(95% CI, 1.8%–87.5%, P = .06) more cases of pneumococcal
meningitis, but the conﬁdence interval crosses the null point.
Streptococcus pneumoniaemeningitis is therefore a seasonal dis-
ease in Malawi occurring in the dry season, particularly hot, dry
months. Cases of NTS meningitis were above the mean in Au-
gust to December and below the mean in January, but the trend
did not reach signiﬁcance. Hib and cryptococcal disease were
not seasonal (data not shown).
CSF Findings by Pathogen
Signiﬁcantly lower CSF WCCs were seen in cases of S. pneumo-
niae meningitis compared with N. meningitidis meningitis in
both adults and children (Table 1). HIV did not inﬂuence the
CSF WCC in pneumococcal meningitis in adults (median CSF
WCC in HIV-positive adults was 435 cells/µL [interquartile
Figure 2. Incidence of culture-positive bacterial meningitis per 100 000 population. A, Incidence and all cases of bacterial meningitis, 2000–2012, in all
cases and children and adolescents aged <20 years. B, Incidence and cases by speciﬁc age group (only children for whom age was known are included).
Figure 3. Cumulative numbers of adults and children alive on antiretro-
viral therapy (ART) per year in the Southern Region of Malawi.
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range {IQR}, 107–1680 cells/µL]; n = 297), compared with 575
cells/µL (IQR, 196–1740 cells/µL) in HIV-negative adults
(n = 44) (P = .31). Both NTS and cryptococcal meningitis were
associated with lower CSF WCC than S. pneumoniae and N.
meningitidis. CSF protein was signiﬁcantly higher in bacterial
meningitis caused by all pathogens (with the exception of NTS)
than in cryptococcal meningitis (P < .001). Similarly, CSF glucose
levels were signiﬁcantly lower in S. pneumoniae compared with
cryptococcus for both adults and children (P < .001).
WCC data were collected for culture-negative CSF specimens
from 2007. Between 2007 and 2010, 643 of 8166 (7.8%) adults
had a negative culture but had a CSFWCC of >100 cells/µL; 796
of 9431 (8.4%) children had a negative culture but had a CSF
WCC of >20 cells/µL. These cases may represent a signiﬁcant
additional meningitis disease burden; we are currently investi-
gating the causes of culture-negative meningitis in our hospital.
DISCUSSION
Our data indicate that culture-conﬁrmed cases of ABM present-
ing to the largest secondary and tertiary referral hospital in Ma-
lawi have declined steeply over the last 12 years, driven largely
Figure 4. Seasonality plot of all meningitis cases caused by Streptococcus pneumoniae (A) and nontyphoidal salmonellae (NTS) (B). A, Seasonality of S.
pneumoniae. B, Seasonality of NTS.
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by a decline in persons aged 3 months to <5 years. This has oc-
curred prior to the addition of the 13-valent pneumococcal con-
jugate vaccine (PCV13) to the routine infant schedule in
Malawi in 2011 but subsequent to the introduction of Hib vac-
cine in 2002. Although a similar decline in Hib ABM that was
ecologically coincident with Hib vaccine introduction has been
observed elsewhere in Africa [26, 27], it is striking that we also
observed a decline in cases of pneumococcal and NTS ABM in
this age group. Why we have not observed a similar overall de-
cline in the incidence of acute adult ABM, in contrast to child-
hood disease, is uncertain.
The decline in childhood cases of S. pneumoniae ABM in
children aged 3 months to <5 years preceding the introduction
of PCV13 has not been observed in other sub-Saharan African
facility-based studies [28], with the exception of HIV-infected
children receiving ART in South Africa [29].We have previous-
ly reported a similar decline in cases of pneumococcal bactere-
mia (IPD) in adults and children [25]. During 2000–20012 in
Malawi, there have been considerable improvements in general
nutrition and the management of childhood illness at primary
healthcare levels, which have been linked to a 50% decline in the
overall under-5 mortality between 1999 and 2009 [30]. Pediatric
ABM has been associated with HIV in 36% of cases in Malawi
[13]. Data on the overall community prevalence of HIV in chil-
dren are unavailable, but the estimated prevalence of HIV in
pregnant women in Southern Malawi has fallen from 19% in
2000 to 14% in 2010 [22]. Furthermore, extensive rollout of
ART for children and a national prevention of mother-to-child
transmission program may be driving down the burden of HIV.
We suggest that these factors, together with some improvement
in socioeconomic indicators [31], are likely to have contributed
to the observed decline in childhood ABM, particularly NTS
and S. pneumoniaemeningitis. Although the control of malaria
has been shown to improve all-cause mortality in other African
settings [32], there has not been a sufﬁciently large decline in
childhood malaria in Malawi to contribute substantially to
this trend [15].
Free ART has been provided in Malawi for adults since 2004,
and to date nearly 360 000 HIV-infected individuals had been
registered in the national ART program in the Southern Region
of Malawi; co-trimoxazole prophylaxis has been widely avail-
able since 2006 [22].The absence of a decline in adult ABM, de-
spite improvements in HIV care including the rollout of ART
and co-trimoxazole, coincident with a fall in the incidence of
IPD, is therefore surprising [25]. We have previously demon-
strated high rates of pneumococcal carriage with broad serotype
diversity in HIV-infected adults despite the initiation of ART
[33]. We therefore speculate that persistent defects in immune
control in the nasopharynx and potentially the CSF compart-
ment could account for the continuing high incidence of pneu-
mococcal ABM in adults.Ta
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Meningitis is seasonal in many parts of the world [34].A bet-
ter understanding of these disease patterns and the potential cli-
matic associations are important for public health planning and
the interpretation of disease incidence. Malawi is geographically
far from countries where epidemic meningitis primarily due to
N. meningitidis, coincident with the hot, dry season has been
described [34, 35]. In Malawi, pneumococcal and NTS menin-
gitis were both seasonal over the last 10 years, peaking in the
cold, dry and hot, wet seasons, respectively. Importantly, sea-
sonality was maintained, even as incidence rates have declined.
Other African centers beyond the meningitis belt have observed
meningitis seasonality in Uganda, but not in Tanzania, al-
though these data are not from centers undertaking long-term
surveillance [36, 37].
Our disease estimates are of minimum incidence, as it is well
described that routine surveillance supported by CSF culture
alone may underestimate meningitis incidence [38]. However,
in a high-HIV-prevalence setting, the causes of culture-negative
meningitis includes tuberculosis. We did not have access to tu-
berculosis culture, so incidence estimates including culture-
negative cases may be inaccurate and are not presented.
Our data have several limitations. Several adult and pediatric
ABM and IPD clinical trials conducted at our center may have
increased case ascertainment. However, following the completion
of these studies, the number of CSF samples processed in the lab-
oratory has remained static. There may have been underascertain-
ment of pathogens due to the unavailability of diagnostic nucleic
acid detection [38]. Although there are no other government-
funded facilities where ABM cases are routinely admitted, pa-
tients may experience signiﬁcant delays in the community and
die undiagnosed, causing further underascertainment [39].
Health centers may have administered parenteral antibiotics
prior to transfer to QECH, but documentation and trends are
not available. There were no changes in either national or hospital
guidelines during this period. Finally, our data set has arisen from
1 center. However, given the similarity of cross-sectional data that
have emerged with other regional settings, it is likely that these
data are generalizable to other HIV-prevalent African countries.
In conclusion, rates of ABM have declined signiﬁcantly in
children but not in adults in Malawi. Hib vaccine introduction
appears to have resulted in the decline of incidence of Hib in
young children, but the highly successful rollout of ART has
not yet resulted in a reduction in the incidence in adults,
among whom the burden remains high. Long-term surveillance
of bacterial meningitis outside the epidemic meningitis belt is
essential in Africa.
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